Cannabinoids in the treatment of cancer anorexia and cachexia: Where have we been, where are we going?

Emily Seymour-Jackson, Barry J.A. Laird*, Judith Sayers, Marie Fallon, Tora S. Solheim, Richard Skipworth

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review

Abstract

Cachexia–anorexia cancer syndrome remains an unmet clinical need with a dearth of treatment and no standard of care. Acting through the endocannabinoid system, cannabinoids are one potential cancer cachexia treatment. Herein, the potential mechanisms for cannabinoids for cancer cachexia are discussed as are previous and ongoing clinical trials.

Original languageEnglish
Article number100292
JournalAsia-Pacific Journal of Oncology Nursing
Volume10
Issue numberSupplement 1
Early online date7 Aug 2023
DOIs
Publication statusPublished - Nov 2023

Keywords / Materials (for Non-textual outputs)

  • Cachexia
  • Cancer
  • Cannabinoids
  • Cytokine
  • Inflammation
  • Interleukin

Fingerprint

Dive into the research topics of 'Cannabinoids in the treatment of cancer anorexia and cachexia: Where have we been, where are we going?'. Together they form a unique fingerprint.

Cite this